.
Kulldorff M and Information Management Services, Inc. SaTScan v6.1: Software for the spatial and space-time scan statistics. .
Lacey JV Jr et al. Petroleum distillate solvents as risk factors for undifferentiated connective tissue disease (UCTD). Am J Epidemiol 1999;149:761.
Laing et al. Racial differences in Scleroderma among women in Michigan. Arthritis and Rheum 1997;40:734-42.
Lambe M et al. Childbearing and the Risk of Scleroderma: A Population-based Study in Sweden. Am J Epidemiol 2004;159:162-166.
Last JM (ed). 1988. A dictionary of epidemiology. 2nd ed. Edited for the International Epidemiological Association. New York: Oxford University Press.
LeRoy EC et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988;2:202-5.
Maddison PJ et al. Antinuclear antibodies in the relatives and spouses of patients with systemic sclerosis. Ann Rheum Dis 1986;45: 793-799.
Maddison PJ. Nature and Nurture in Systemic Lupus Erythematosus. Rheumatic Dermatology 1999:7-13.
Maricq HR et al. Prevalence of Scleroderma Spectrum Disorders in the General Population of South Carolina. Arthritis Rheum 1989;32(8):998-1006.
Massachusetts Department of Environmental Protection (MDEP). Consent Order and Notice of Noncompliance to Boston Edison Company, Boston MA. January 1991.
Massachusetts Department of Environmental Protection (MDEP). 310.CMR 40.0000 Massachusetts Contingency Plan. MDEP, Bureau of Waste Site Cleanup. 1997.
Massachusetts Department of Environmental Protection (MDEP). Waste Site Cleanup Notification and Status [database]. 2007a: Massachusetts Department of Environmental Protection (MDEP). Pre-1993 Spills [database]. 2007b: Mayes MD. Scleroderma Epidemiology. Rheum Dis Clin North Am 1996;22(4):751-64.
Mayes MD. Epidemiologic Studies of Environmental Agents and Systemic Autoimmune Diseases. Environ Health Perspect 1999;107S:743-748.
Mayes, MD. Scleroderma Epidemiology. Rheum Dis Clin North Am 2003;29:239-254.
Medsger TA. Epidemiology of Systemic Sclerosis. Clin Dermatol 1994;12:207-216.
Meier CR et al. Postmenopausal Estrogen Replacement Therapy and the Risk of Developing Systemic Lupus Erythematosus or Discoid Lupus. J Rheumatol 1998;25:1515-9.
Michet JC et al. Epidemiology of Systemic Lupus Erythematosus and Other Connective Tissue Diseases in Rochester, Minnesota, 1950 through 1979. Mayo Clin Proc 1985;60:105-113.
Nietert PJ et al. Is occupational organic solvent exposure a risk factor for scleroderma? [published erratum appears in Arthritis Rheum 1998 Aug;41(8):1512] Arthritis Rheum 1998;41:1111.
Parks CG et al. Occupational Exposure to Crystalline Silica and Autoimmune Disease. Env Health Persp 1999;107(5):793-802.
Parks, Christine et al. Occupational Exposure to Crystalline Silica and Risk of Systemic Lupus Erythematosus. Arthritis Rheum 2002;46:1840-50.
Pelmear PL et al. Occupationally-Induced Scleroderma. J Occup Med January 1992:20-25.
Pisa EP et al. Reproductive Factors and the Risk of Scleroderma: An Italian Case-Control Study. Arthritis Rheum 2002;46:451-456.
RAM Environmental LLC. (RAM), 1996. Phase I Initial Site Investigation Report: No. 6 Fuel Oil Release, New Boston Station, Boston Edison Company, 776 Summer Street, South Boston, MA RTN# 3-13007, October 4, 1996.
Roberts-Thomson PJ et al. Scleroderma in South Australia: epidemiological observations of possible pathogenic significance. Intern Med J 2001;31:220-229.
Roberts-Thomson PJ et al. Scleroderma in South Australia: further epidemiological observations supporting a stochastic explanation. Intern Med J 2006;36:L489-497.
Rothman KJ. 1986. Modern Epidemiology. Boston: Little, Brown and Company.
SAS®. 2006. SAS Software, version 9.1. 3. 2002-2006. SAS Institute Inc. Cary, NC.
Sanchez-Guerrero J et al. Postmenopausal Estrogen Therapy and the Risk for Developing Systemic Lupus Erythematosus. Ann Intern Med 1995;122:430-433.
Sanchez-Guerrero J et al. Past Use of Oral Contraceptives and the Risk of Developing Systemic Lupus Erythematosus. Arthritis Rheum 1997;40:804-808.
Schlesselman J. 1982. Case-control studies design, conduct and analysis. Oxford University Press, Inc.
Silman AJ et al. Geographical Clustering of Scleroderma in South and West London, Br J Rheumatol 1990;29:92.
Silman AJ and Jones S. What is the contribution of occupational environmental factors to the occurrence of scleroderma in men? Ann Rheum Dis 1992;51:1322.
Silman AJ and Hochberg MC. Occupational and Environmental Influences on Scleroderma. Rheum Dis Clin North Am 1996;22(4):737-749.
Simard JF and Costenbader KF. What can epidemiology tell us about systemic lupus erythematosus? Int J Clin Pract 2007;61:1170-1180.
Steen VD et.al. Incidence of systemic sclerosis in Allegeheny County, Pennsylvania. Arthritis & Rheumatism 1997:40(3) 441-445.
Steenland K and Brown D. Mortality Study of Gold Miners Exposed to Silica and Nonasbestiform Amphibole Minerals: An Update with 14 More Years of Follow-Up. Am J Ind Med 1995;27:217-229.
Strom BL et al. Shingles, allergies, family medical history, oral contraceptives, and other potential risk factors for systemic lupus erythematosus. Am J Epidemiol 1994;40:632-42.
Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee (Subcommittee for SSc). Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980;23:581-90.
Tabuenca JM. Toxic-allergic syndrome caused by ingestion of rapeseed oil denatured with aniline. Lancet 1981;2:567.
Tan et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
Town Online. Exploring Boston’s Neighborhoods: South Boston. 30 June 2000.
